Liposomal DDS Technology Market, Global Outlook and Forecast 2022-2028

August 2022 | 63 pages | ID: LF1E8C21F837EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Liposomal DDS Technology in Global, including the following market information:

Global Liposomal DDS Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Liposomal DDS Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Liposomal Doxorubicin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Liposomal DDS Technology include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomal DDS Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Liposomal DDS Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Liposomal DDS Technology Market Segment Percentages, by Type, 2021 (%)

• Liposomal Doxorubicin
• Liposomal Amphoteracin B
• Liposomal Paclitaxel
• Others

Global Liposomal DDS Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Liposomal DDS Technology Market Segment Percentages, by Application, 2021 (%)

• Fungal Infection Therapy
• Cancer & Tumor Therapy
• Others

Global Liposomal DDS Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Liposomal DDS Technology Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Liposomal DDS Technology revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Liposomal DDS Technology revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences
• Pacira
• Sun Pharmaceutical
• Johnson & Johnson
• Luye Pharma
• Sigma-Tau
• Ipsen (Onivyde)
• CSPC
• Teva Pharmaceutical
• Novartis
• Fudan-Zhangjiang

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Liposomal DDS Technology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Liposomal DDS Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIPOSOMAL DDS TECHNOLOGY OVERALL MARKET SIZE

2.1 Global Liposomal DDS Technology Market Size: 2021 VS 2028
2.2 Global Liposomal DDS Technology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Liposomal DDS Technology Players in Global Market
3.2 Top Global Liposomal DDS Technology Companies Ranked by Revenue
3.3 Global Liposomal DDS Technology Revenue by Companies
3.4 Top 3 and Top 5 Liposomal DDS Technology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liposomal DDS Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposomal DDS Technology Players in Global Market
  3.6.1 List of Global Tier 1 Liposomal DDS Technology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Liposomal DDS Technology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Liposomal DDS Technology Market Size Markets, 2021 & 2028
  4.1.2 Liposomal Doxorubicin
  4.1.3 Liposomal Amphoteracin B
  4.1.4 Liposomal Paclitaxel
  4.1.5 Others
4.2 By Type - Global Liposomal DDS Technology Revenue & Forecasts
  4.2.1 By Type - Global Liposomal DDS Technology Revenue, 2017-2022
  4.2.2 By Type - Global Liposomal DDS Technology Revenue, 2023-2028
  4.2.3 By Type - Global Liposomal DDS Technology Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Liposomal DDS Technology Market Size, 2021 & 2028
  5.1.2 Fungal Infection Therapy
  5.1.3 Cancer & Tumor Therapy
  5.1.4 Others
5.2 By Application - Global Liposomal DDS Technology Revenue & Forecasts
  5.2.1 By Application - Global Liposomal DDS Technology Revenue, 2017-2022
  5.2.2 By Application - Global Liposomal DDS Technology Revenue, 2023-2028
  5.2.3 By Application - Global Liposomal DDS Technology Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Liposomal DDS Technology Market Size, 2021 & 2028
6.2 By Region - Global Liposomal DDS Technology Revenue & Forecasts
  6.2.1 By Region - Global Liposomal DDS Technology Revenue, 2017-2022
  6.2.2 By Region - Global Liposomal DDS Technology Revenue, 2023-2028
  6.2.3 By Region - Global Liposomal DDS Technology Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Liposomal DDS Technology Revenue, 2017-2028
  6.3.2 US Liposomal DDS Technology Market Size, 2017-2028
  6.3.3 Canada Liposomal DDS Technology Market Size, 2017-2028
  6.3.4 Mexico Liposomal DDS Technology Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Liposomal DDS Technology Revenue, 2017-2028
  6.4.2 Germany Liposomal DDS Technology Market Size, 2017-2028
  6.4.3 France Liposomal DDS Technology Market Size, 2017-2028
  6.4.4 U.K. Liposomal DDS Technology Market Size, 2017-2028
  6.4.5 Italy Liposomal DDS Technology Market Size, 2017-2028
  6.4.6 Russia Liposomal DDS Technology Market Size, 2017-2028
  6.4.7 Nordic Countries Liposomal DDS Technology Market Size, 2017-2028
  6.4.8 Benelux Liposomal DDS Technology Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Liposomal DDS Technology Revenue, 2017-2028
  6.5.2 China Liposomal DDS Technology Market Size, 2017-2028
  6.5.3 Japan Liposomal DDS Technology Market Size, 2017-2028
  6.5.4 South Korea Liposomal DDS Technology Market Size, 2017-2028
  6.5.5 Southeast Asia Liposomal DDS Technology Market Size, 2017-2028
  6.5.6 India Liposomal DDS Technology Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Liposomal DDS Technology Revenue, 2017-2028
  6.6.2 Brazil Liposomal DDS Technology Market Size, 2017-2028
  6.6.3 Argentina Liposomal DDS Technology Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Liposomal DDS Technology Revenue, 2017-2028
  6.7.2 Turkey Liposomal DDS Technology Market Size, 2017-2028
  6.7.3 Israel Liposomal DDS Technology Market Size, 2017-2028
  6.7.4 Saudi Arabia Liposomal DDS Technology Market Size, 2017-2028
  6.7.5 UAE Liposomal DDS Technology Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Gilead Sciences
  7.1.1 Gilead Sciences Corporate Summary
  7.1.2 Gilead Sciences Business Overview
  7.1.3 Gilead Sciences Liposomal DDS Technology Major Product Offerings
  7.1.4 Gilead Sciences Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.1.5 Gilead Sciences Key News
7.2 Pacira
  7.2.1 Pacira Corporate Summary
  7.2.2 Pacira Business Overview
  7.2.3 Pacira Liposomal DDS Technology Major Product Offerings
  7.2.4 Pacira Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.2.5 Pacira Key News
7.3 Sun Pharmaceutical
  7.3.1 Sun Pharmaceutical Corporate Summary
  7.3.2 Sun Pharmaceutical Business Overview
  7.3.3 Sun Pharmaceutical Liposomal DDS Technology Major Product Offerings
  7.3.4 Sun Pharmaceutical Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.3.5 Sun Pharmaceutical Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Liposomal DDS Technology Major Product Offerings
  7.4.4 Johnson & Johnson Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Luye Pharma
  7.5.1 Luye Pharma Corporate Summary
  7.5.2 Luye Pharma Business Overview
  7.5.3 Luye Pharma Liposomal DDS Technology Major Product Offerings
  7.5.4 Luye Pharma Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.5.5 Luye Pharma Key News
7.6 Sigma-Tau
  7.6.1 Sigma-Tau Corporate Summary
  7.6.2 Sigma-Tau Business Overview
  7.6.3 Sigma-Tau Liposomal DDS Technology Major Product Offerings
  7.6.4 Sigma-Tau Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.6.5 Sigma-Tau Key News
7.7 Ipsen (Onivyde)
  7.7.1 Ipsen (Onivyde) Corporate Summary
  7.7.2 Ipsen (Onivyde) Business Overview
  7.7.3 Ipsen (Onivyde) Liposomal DDS Technology Major Product Offerings
  7.7.4 Ipsen (Onivyde) Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.7.5 Ipsen (Onivyde) Key News
7.8 CSPC
  7.8.1 CSPC Corporate Summary
  7.8.2 CSPC Business Overview
  7.8.3 CSPC Liposomal DDS Technology Major Product Offerings
  7.8.4 CSPC Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.8.5 CSPC Key News
7.9 Teva Pharmaceutical
  7.9.1 Teva Pharmaceutical Corporate Summary
  7.9.2 Teva Pharmaceutical Business Overview
  7.9.3 Teva Pharmaceutical Liposomal DDS Technology Major Product Offerings
  7.9.4 Teva Pharmaceutical Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.9.5 Teva Pharmaceutical Key News
7.10 Novartis
  7.10.1 Novartis Corporate Summary
  7.10.2 Novartis Business Overview
  7.10.3 Novartis Liposomal DDS Technology Major Product Offerings
  7.10.4 Novartis Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.10.5 Novartis Key News
7.11 Fudan-Zhangjiang
  7.11.1 Fudan-Zhangjiang Corporate Summary
  7.11.2 Fudan-Zhangjiang Business Overview
  7.11.3 Fudan-Zhangjiang Liposomal DDS Technology Major Product Offerings
  7.11.4 Fudan-Zhangjiang Liposomal DDS Technology Revenue in Global Market (2017-2022)
  7.11.5 Fudan-Zhangjiang Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Liposomal DDS Technology Market Opportunities & Trends in Global Market
Table 2. Liposomal DDS Technology Market Drivers in Global Market
Table 3. Liposomal DDS Technology Market Restraints in Global Market
Table 4. Key Players of Liposomal DDS Technology in Global Market
Table 5. Top Liposomal DDS Technology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liposomal DDS Technology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liposomal DDS Technology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liposomal DDS Technology Product Type
Table 9. List of Global Tier 1 Liposomal DDS Technology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal DDS Technology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liposomal DDS Technology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liposomal DDS Technology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liposomal DDS Technology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Liposomal DDS Technology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liposomal DDS Technology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liposomal DDS Technology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Liposomal DDS Technology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liposomal DDS Technology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liposomal DDS Technology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liposomal DDS Technology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liposomal DDS Technology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liposomal DDS Technology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liposomal DDS Technology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liposomal DDS Technology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liposomal DDS Technology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liposomal DDS Technology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liposomal DDS Technology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liposomal DDS Technology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liposomal DDS Technology Revenue, (US$, Mn), 2023-2028
Table 30. Gilead Sciences Corporate Summary
Table 31. Gilead Sciences Liposomal DDS Technology Product Offerings
Table 32. Gilead Sciences Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 33. Pacira Corporate Summary
Table 34. Pacira Liposomal DDS Technology Product Offerings
Table 35. Pacira Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 36. Sun Pharmaceutical Corporate Summary
Table 37. Sun Pharmaceutical Liposomal DDS Technology Product Offerings
Table 38. Sun Pharmaceutical Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Liposomal DDS Technology Product Offerings
Table 41. Johnson & Johnson Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 42. Luye Pharma Corporate Summary
Table 43. Luye Pharma Liposomal DDS Technology Product Offerings
Table 44. Luye Pharma Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 45. Sigma-Tau Corporate Summary
Table 46. Sigma-Tau Liposomal DDS Technology Product Offerings
Table 47. Sigma-Tau Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 48. Ipsen (Onivyde) Corporate Summary
Table 49. Ipsen (Onivyde) Liposomal DDS Technology Product Offerings
Table 50. Ipsen (Onivyde) Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 51. CSPC Corporate Summary
Table 52. CSPC Liposomal DDS Technology Product Offerings
Table 53. CSPC Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Liposomal DDS Technology Product Offerings
Table 56. Teva Pharmaceutical Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 57. Novartis Corporate Summary
Table 58. Novartis Liposomal DDS Technology Product Offerings
Table 59. Novartis Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)
Table 60. Fudan-Zhangjiang Corporate Summary
Table 61. Fudan-Zhangjiang Liposomal DDS Technology Product Offerings
Table 62. Fudan-Zhangjiang Liposomal DDS Technology Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Liposomal DDS Technology Segment by Type in 2021
Figure 2. Liposomal DDS Technology Segment by Application in 2021
Figure 3. Global Liposomal DDS Technology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liposomal DDS Technology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposomal DDS Technology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liposomal DDS Technology Revenue in 2021
Figure 8. By Type - Global Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 12. US Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 16. Germany Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 17. France Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 24. China Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 28. India Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 30. Brazil Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liposomal DDS Technology Revenue Market Share, 2017-2028
Figure 33. Turkey Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liposomal DDS Technology Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead Sciences Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pacira Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sun Pharmaceutical Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Luye Pharma Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sigma-Tau Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Ipsen (Onivyde) Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. CSPC Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novartis Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fudan-Zhangjiang Liposomal DDS Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)